Elkfork Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$112M Buy
867,636
+72,520
+9% +$9.55M 2.73% 4
2019
Q2
$111M Buy
795,116
+46,928
+6% +$6.5M 2.71% 4
2019
Q1
$105M Buy
748,188
+20,440
+3% +$2.74M 2.62% 5
2018
Q4
$93.9M Sell
727,748
-1,372
-0.2% -$191K 2.65% 4
2018
Q3
$101M Sell
729,120
-54,628
-7% -$7.26M 2.39% 4
2018
Q2
$95.1M Sell
783,748
-53,200
-6% -$6.64M 2.45% 4
2018
Q1
$107M Sell
836,948
-1,120
-0.1% -$151K 2.89% 3
2017
Q4
$117M Sell
838,068
-37,296
-4% -$5.19M 3.18% 3
2017
Q3
$114M Sell
875,364
-31,220
-3% -$4.14M 3.3% 3
2017
Q2
$120M Sell
906,584
-57,876
-6% -$7.38M 3.61% 3
2017
Q1
$120M Sell
964,460
-32,508
-3% -$3.88M 3.69% 3
2016
Q4
$115M Buy
+996,968
New +$115M 3.78% 3

Other funds holding JNJ

Elkfork Partners's JNJ Position: Q3 2019 in Review

Elkfork Partners increased its Johnson & Johnson (JNJ) stake by 9.1% in Q3 2019, buying an estimated $9.55M and bringing the position to 867,636 shares worth $112M. The position accounts for 2.73% of the portfolio, ranked #4.

Elkfork Partners first reported a position in JNJ in Q4 2016 and has held it in 12 quarters since. The position peaked at $120M in Q1 2017. 2,725 funds tracked by Wall St. Rank hold JNJ as of Q3 2019.

  • Elkfork Partners held 867,636 shares of Johnson & Johnson worth $112M as of Q3 2019.
  • Elkfork Partners bought 72,520 Johnson & Johnson shares in Q3 2019, an estimated $9.55M.
  • Johnson & Johnson made up 2.73% of Elkfork Partners's portfolio in Q3 2019, its #4 holding.
  • Elkfork Partners first reported a position in Johnson & Johnson in Q4 2016 and has held it in 12 quarters since.
  • Elkfork Partners's Johnson & Johnson position peaked at $120M in Q1 2017.
  • 2,725 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.